Company
Tandem Diabetes Care
Public · Nasdaq: TNDMUnited States
Tandem Diabetes Care manufactures and sells advanced automated insulin delivery systems and insulin pumps.
Tandem Diabetes Care is a publicly traded company, based in the United States. It trades on the Nasdaq under the ticker TNDM.
Recent developments
AI summary of recent coverageRecent coverage of Tandem Diabetes Care has centered on the company's third-quarter earnings results, which beat expectations and prompted analyst price target increases, as well as a significant leadership transition with the appointment of a new chief executive from GE HealthCare following the retirement of the incumbent CEO. The company also provided 2026 sales guidance ranging from $1.065 billion to $1.085 billion.
Summarized from the headlines in the sidebar; see each source for the full story.